"Demand-based molecular diagnostics" typically refers to the approach of performing molecular diagnostic tests based on specific clinical or healthcare demands. This term emphasizes the tailored use of molecular testing to meet specific needs or requests rather than routine or universal testing protocols.
At Cluegenix we are expert in developing assays based on the following -
Clinical Relevance: Demand-based molecular diagnostics focus on testing that is directly relevant to the clinical situation of individual patients or specific healthcare scenarios.
Customization: It involves customizing the use of molecular tests based on factors such as patient symptoms, medical history, risk factors, or the stage of disease.
Diagnostic Precision: By aligning molecular testing with specific clinical demands, healthcare providers can more accurately diagnose diseases, monitor treatment responses, predict outcomes, and guide personalized therapeutic decisions.
Epidemiological and Public Health Applications: Demand-based molecular diagnostics are also relevant in epidemiological investigations and public health responses.
Infectious Diseases: Testing for specific pathogens based on patient symptoms, travel history, or epidemiological context (e.g., PCR testing for COVID-19 during a pandemic).
Cancer Diagnostics: Molecular profiling of tumors to guide targeted therapy selection based on genetic mutations or biomarker expression.
Genetic Disorders: Genetic testing based on family history or clinical suspicion to diagnose inherited conditions.
Transplant Medicine: HLA typing and infectious disease screening tailored to transplant candidates and recipients.
Resource Optimization:
Patient-Centered Care:
Cost-Effectiveness: